$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!

Biogen Inc.
(NASDAQ : BIIB)

( )
BIIB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading BIIB News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.68%81.471.6%$1008.08m
BIIBBiogen Inc.
0.43%318.171.2%$628.57m
AMGNAmgen Inc.
0.03%174.401.0%$523.71m
CELGCelgene Corporation
-0.17%114.010.8%$507.23m
MDVNMedivation, Inc.
-0.19%80.271.8%$360.64m
REGNRegeneron Pharmaceuticals, Inc.
0.47%420.613.4%$322.62m
ILMNIllumina, Inc.
-0.55%172.794.4%$241.54m
BMRNBioMarin Pharmaceutical Inc.
1.28%99.433.6%$206.66m
ALXNAlexion Pharmaceuticals, Inc.
0.65%137.422.6%$202.27m
VRTXVertex Pharmaceuticals Incorporated
0.03%100.992.3%$126.97m
EXASExact Sciences Corporation
-1.78%20.4330.9%$124.73m
IONSIonis Pharmaceuticals, Inc.
-0.47%33.7111.1%$99.57m
INCYIncyte Corporation
-0.10%81.902.6%$93.48m
AAgilent Technologies, Inc.
0.50%47.820.9%$91.87m
TSROTESARO, Inc.
-6.39%92.7615.8%$88.11m

Company Profile

Biogen, Inc. is a global biotechnology company, which develops markets and manufactures therapies for people living with neurological, autoimmune and hematologic disorders. Its products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI, and FAMPYRA for multiple sclerosis, ALPROLIX for hemophilia B and ELOCTATE for hemophilia A. The company also collaborates on the development and commercialization of RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and other conditions and share profits and losses for GAZYVA which is approved for the treatment of chronic lymphocytic leukemia. Biogen was founded by Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.